The smoker's paradox and the real risk of smoking

被引:12
|
作者
Kunz, F [1 ]
Pechlaner, C
Hörtnagl, H
Pfister, R
机构
[1] Innsbruck Med Univ, Dept Internal Med, Innsbruck, Austria
[2] Innsbruck Med Univ, Dept Sports & Cardiovasc Med, Innsbruck, Austria
关键词
cholesterol; coronary risk; physical activity; smoking; testosterone;
D O I
10.1007/s10654-004-3004-x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
No satisfactory explanations have been offered for the smoker's paradox, the greater short-term survival of smokers after a myocardial infarction nor for the large variations in the coronary risk rate for smoking ranging between 1 and 5.9. These discrepancies as well as the smoker's paradox may be caused by different baseline characteristics of smokers and nonsmokers, whereas the usually quoted coronary risk of 2 is derived from studies based on the assumption of equal baseline characteristics. As neither this assumption nor the possibility of unequal starting conditions have been tested, we examined the main cardiovascular risk factors in smoking and nonsmoking boys as near as possible to baseline, at the age of fourteen. This age appeared to be best suited, because boys starting to smoke early are most likely to become regular and heavy smokers. Of 336 boys, 39 had smoked 8.3 +/- 6.0 cigarettes/day for 15.5 +/- 11.2 months. Compared to nonsmokers, boys who started to smoke early had lower LDL cholesterol and alpha(2)-antiplasmin, greater handgrip strength, vital capacity and forced expiratory volume, better perfomance on bicycle ergometry and higher testosterone. The differences in total cholesterol, LDL cholesterol, vital capacity, handgrip strength, testosterone and alpha(2)-antiplasmin persisted after adjustment for age, body mass, and testosterone. In addition, the differences in perfomance on bicycle ergometry and forced expiratory volume persisted after adjustment for age. These favourable baseline characteristics of those starting to smoke early can explain the smoker's paradox. In addition, they suggest that the individual coronary risk in smokers is considerably higher than 2, because the assumption of equal baseline characteristics of smokers and nonsmokers cannot be upheld.
引用
收藏
页码:161 / 167
页数:7
相关论文
共 50 条
  • [1] The smoker’s paradox and the real risk of smoking
    Friedebert Kunz
    Christoph Pechlaner
    Helmut Hörtnagl
    Rudolf Pfister
    [J]. European Journal of Epidemiology, 2005, 20 : 161 - 167
  • [2] A real smoker's paradox - Reply
    van Domburg, RT
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (07) : 2009 - 2010
  • [3] Does smoking reduce restenosis? The smoker's paradox revisited
    Cohen, DJ
    Rodriguez, O
    Chauhan, MS
    Kuntz, RE
    [J]. CIRCULATION, 1998, 98 (17) : 511 - 512
  • [4] Impact of smoking on coronary heart disease: is there a smoker's paradox?
    Yahagi, Kazuyuki
    Joner, Michael
    Virmani, Renu
    [J]. CORONARY ARTERY DISEASE, 2015, 26 (06) : 466 - 468
  • [5] The smoker's paradox in acute coronary syndrome - Is it real?
    Coutinho Cruz, M.
    Ilhao Moreira, R.
    Abreu, A.
    Timoteo, A. T.
    Nogueira, M.
    Monteiro, A.
    Portugal, G.
    Pinto Teixeira, P.
    Aguiar Rosa, S.
    Rodrigues, I.
    Almeida Morais, L.
    Modas Daniel, P.
    Carvalho, R.
    Ferreira, L.
    Cruz Ferreira, R.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 554 - 554
  • [6] The smoker's paradox in acute coronary syndrome: Is it real?
    Cruz, Madalena Coutinho
    Moreira, Rita Ilhao
    Abreu, Ana
    Timoteo, Ana Teresa
    Carvalho, Ramiro Sa
    Ferreira, Lurdes
    Ferreira, Rui Cruz
    [J]. REVISTA PORTUGUESA DE CARDIOLOGIA, 2018, 37 (10) : 847 - 855
  • [7] Is There A Smoker's Paradox? Is There An Obesity Paradox? Is There An Obese-Smoker Double Paradox?
    Redel-Traub, Gabriel
    Lee, Jae
    Kim, Michael
    Perwaiz, Meraj
    Brennan, Christina
    Vidi, Venkatesan D.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (15) : B186 - B187
  • [8] Clopidogrel and ischemic stroke outcomes by smoking status: Smoker's paradox?
    Zhang, Qian
    Wang, Yuan
    Song, Haiqing
    Hou, Chengbei
    Cao, Qingyu
    Dong, Kai
    Huang, Xiaoqin
    Feng, Wuwei
    Ovbiagele, Bruce
    Wang, Moli
    Ji, Xunming
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 373 : 41 - 44
  • [9] Investigation of smoking on the antiplatelet response to clopidogrel: Unravelling the smoker's paradox
    Plakogiannis, Frank A.
    Weidmann, Jakob
    Fraser, Blake
    Kwong, Justin
    Asi, Diana
    Kumar, Pratham
    Baldock, Madeleine
    Naamo, Jasmine
    Baluja, Ruhani
    Catanzariti, Rachelle
    Yeung, Stewart
    Pont, Lisa
    Williams, Kylie
    De Rubis, Gabriele
    Dua, Kamal
    Bukhari, Nadeem Irfan
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2024, 257
  • [10] Smoking and Clopidogrel Response Revisited Hemoglobin Levels Explaining the Smoker's Paradox
    Sibbing, Dirk
    Gross, Lisa
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (16) : 1691 - 1693